documents: FDA-2021-N-0515-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2021-N-0515-0002 | FDA | FDA-2021-N-0515 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Postmarketing Adverse Experience Reporting and Recordkeeping for Drug and Biological Products | Notice | 30 Day Proposed Information Collection | 2021-11-05T04:00:00Z | 2021 | 11 | 2021-11-05T04:00:00Z | 2021-12-07T04:59:59Z | 2021-11-05T17:18:42Z | 2021-24236 | 0 | 0 | 0900006484e23a30 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref